A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults.
Vaccines (Basel). 2020 Jun 10;8(2):296. doi: 10.3390/vaccines8020296.
Vaccines (Basel). 2020.
PMID: 32532097
Free PMC article.